Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
USP
ANALYTICAL
ABOUT THIS PAGE
Severity: Warning
Message: include(../assets/text/seoInfo/464205.txt): Failed to open stream: No such file or directory
Filename: include/seoInfo.php
Line Number: 77
Backtrace:
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: _error_handler
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: include
File: /var/www/html/application/views/include/product/indexNew.php
Line: 1266
Function: include
File: /var/www/html/application/views/commonNew.php
Line: 442
Function: include
File: /var/www/html/application/controllers/Search.php
Line: 1720
Function: view
File: /var/www/html/index.php
Line: 224
Function: require_once
Severity: Warning
Message: include(): Failed opening '../assets/text/seoInfo/464205.txt' for inclusion (include_path='.:/usr/share/pear:/usr/share/php')
Filename: include/seoInfo.php
Line Number: 77
Backtrace:
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: _error_handler
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: include
File: /var/www/html/application/views/include/product/indexNew.php
Line: 1266
Function: include
File: /var/www/html/application/views/commonNew.php
Line: 442
Function: include
File: /var/www/html/application/controllers/Search.php
Line: 1720
Function: view
File: /var/www/html/index.php
Line: 224
Function: require_once
A Tenofovir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tenofovir, including repackagers and relabelers. The FDA regulates Tenofovir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tenofovir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tenofovir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tenofovir supplier is an individual or a company that provides Tenofovir active pharmaceutical ingredient (API) or Tenofovir finished formulations upon request. The Tenofovir suppliers may include Tenofovir API manufacturers, exporters, distributors and traders.
click here to find a list of Tenofovir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tenofovir DMF (Drug Master File) is a document detailing the whole manufacturing process of Tenofovir active pharmaceutical ingredient (API) in detail. Different forms of Tenofovir DMFs exist exist since differing nations have different regulations, such as Tenofovir USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tenofovir DMF submitted to regulatory agencies in the US is known as a USDMF. Tenofovir USDMF includes data on Tenofovir's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tenofovir USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tenofovir suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tenofovir Drug Master File in Japan (Tenofovir JDMF) empowers Tenofovir API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tenofovir JDMF during the approval evaluation for pharmaceutical products. At the time of Tenofovir JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tenofovir suppliers with JDMF on PharmaCompass.
A Tenofovir written confirmation (Tenofovir WC) is an official document issued by a regulatory agency to a Tenofovir manufacturer, verifying that the manufacturing facility of a Tenofovir active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tenofovir APIs or Tenofovir finished pharmaceutical products to another nation, regulatory agencies frequently require a Tenofovir WC (written confirmation) as part of the regulatory process.
click here to find a list of Tenofovir suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tenofovir as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tenofovir API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tenofovir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tenofovir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tenofovir NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tenofovir suppliers with NDC on PharmaCompass.
Tenofovir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tenofovir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tenofovir GMP manufacturer or Tenofovir GMP API supplier for your needs.
A Tenofovir CoA (Certificate of Analysis) is a formal document that attests to Tenofovir's compliance with Tenofovir specifications and serves as a tool for batch-level quality control.
Tenofovir CoA mostly includes findings from lab analyses of a specific batch. For each Tenofovir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tenofovir may be tested according to a variety of international standards, such as European Pharmacopoeia (Tenofovir EP), Tenofovir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tenofovir USP).
LOOKING FOR A SUPPLIER?
